Status:
COMPLETED
CE-IOUS Impact on Surgical Strategy of Liver Tumours and Liver Metastases
Lead Sponsor:
University of Regensburg
Conditions:
Liver Neoplasms
Liver/Hepatobiliary Cancer
Eligibility:
All Genders
Brief Summary
Contrast-enhanced intraoperative ultrasound (CE-IOUS) plays an increasingly important role in the surgical therapy planning of primary liver lesions as well as liver metastases. The present study was...
Detailed Description
CE-IOUS has been used during hepatobiliary surgery for almost 25 years. During this time, it has proven to be an excellent diagnostic tool for detecting and characterising previously unknown lesions. ...
Eligibility Criteria
Inclusion
- Operations during study period from 01/2017 until 12/2019
- Elective liver surgery in the department of surgery at the University Hospital Regensburg
- Liver resections due to primary hepatic tumours (benign, malignant) or hepatic metastases
- Liver surgery with intraoperative use of CE-IOUS
Exclusion
- Intraoperative use of CE-IOUS outside the department of surgery
- Liver transplantations
- Use of CE-IOUS only for exclusion of hepatic metastasis
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05261113
Start Date
January 1 2017
End Date
June 30 2021
Last Update
March 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Department of Surgery
Regensburg, Germany